Journey Medical Corporation DERM Business Segments — Total Costs & Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Journey Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Journey Medical Corporation's business segments — total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Journey Medical Corporation's business segments — total costs & expenses?
- Journey Medical Corporation (DERM) reported business segments — total costs & expenses of $18.19M in Q1 2026.
- How has Journey Medical Corporation's business segments — total costs & expenses changed year-over-year?
- Journey Medical Corporation's business segments — total costs & expenses increased by 5.7% year-over-year, from $17.21M to $18.19M.
- What does business segments — total costs & expenses mean?
- This metric aggregates all operating costs incurred by the dermatological segment, including cost of goods sold, research and development, selling, marketing, and administrative expenses. It serves as a comprehensive measure of the total resource consumption required to maintain and grow the segment's market presence. Analyzing this total allows stakeholders to evaluate the overall cost structure and operational scale of the business unit.